GAIA-Health
Financiado
GAIA Health microbiome suite for personalized medicine
GAIA-Health: microbiome suite for personalized medicine
Genomic revolution is transforming our approach to treat patients by individualizing treatments that reduce adverse events and in turn decrease health care costs. Microbiome...
GAIA-Health: microbiome suite for personalized medicine
Genomic revolution is transforming our approach to treat patients by individualizing treatments that reduce adverse events and in turn decrease health care costs. Microbiome analysis can in fact be used for diagnosis and potentially prognosis of various diseases such as cancer, Crohn’s disease, metabolic disorders, reproductive health and skin pathologies and infections, as well as autoimmune, respiratory and mental diseases. Due to its broad adoption in a variety of medical and biotech domains, the global human microbiome market is witnessing an annual growth rate (CAGR) of 18,5%.
However, the the cost and the complexity of microbiome data analysis and management represents the main bottleneck in this market, preventing a broader adoption of personalized medicine and diagnostic, as well as the discovery of new therapeutic targets where there is a lack of treatments for specific diseases.
Our product - GAIA Health - bridges the gap between data production and interpretation in the health, diagnostic and biotech sector. Gaia-Health is a cutting edge omics tool that is able to detect, quantify and evaluate the biological composition of any type of sample of human microbiome (gut, skin, mouth and biofluid). GAIA Health offers unique insights into human health. It is the solution for every customer who needs customized microbiome analysis with superior precision and detection power, for faster, easier and effective personalized medicine, treatments and therapies. GAIA-Health stands apart from its competitors because of its superior precision and detection power; a Multi-diagnosis system - for this first type Gut, Skin, Mouth and Reproductive Health Analysis in one suite; and its Immediately actionable results, allowing faster and more reliable decision making .
ver más
Duración del proyecto: 6 meses
Fecha Inicio: 2019-05-06
Fecha Fin: 2019-11-30
Fecha Fin: 2019-11-30
Línea de financiación: concedida
El organismo H2020 notifico la concesión del proyecto el día 2019-11-30
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
EIC-SMEInst-2018-2020:
SME instrument
Cerrada
hace 6 años
Presupuesto
El presupuesto total del proyecto asciende a
71K€
Líder del proyecto
SEQUENTIA BIOTECH
Investigacion, desarrollo e innovacion, actividades cientificas y tecnicas, informacion y comunicacines, informatica, telecomunicaciones y o...
Perfil tecnológico
TRL
4-5
130K
Perfil tecnológico
TRL
4-5
130K